Objectives To review the effects and safety of high-flow nasal cannula (HFNC) for
bronchiolitis. Methods Six electronic databases including PubMed, EMBASE, Cochrane …

Background To assess the published evidence to establish the efficacy and safety of high
flow oxygen cannula (HFNC) as respiratory support for children up to 24 months of age with …

Bronchiolitis is a common respiratory illness in early childhood, often leading to
hospitalization and associated healthcare costs. Low flow 100% oxygen through nasal …

Background The objective was to determine whether high-flow nasal cannula (HFNC), a
promising respiratory support in infant bronchiolitis, could reduce the proportion of treatment …

Background Bronchiolitis imposes the largest health care burden on non-elective paediatric
hospital admissions worldwide, with up to 15% of cases requiring admission to intensive …

Background Viral bronchiolitis is the leading cause of hospitalization in children during the
first 12 months of life. There is evidence to support the use of noninvasive ventilation in …

Aim To obtain data on the safety and clinical impact of managing infants with bronchiolitis on
the ward with high‐flow nasal cannula (HFNC) treatment. Methods A prospective pilot study …

Aim An observational study was carried out on infants with moderate to severe bronchiolitis
to compare the clinical outcomes following treatment with a high‐flow nasal cannula (HFNC) …

The effectiveness of using a face mask with a small diffuser for oxygen delivery (OxyMask)
was compared to use of a high-flow nasal cannula (HFNC) in patients with moderate or …

High-flow nasal cannula (HFNC) is a widely used ventilatory support in children with
bronchiolitis in the intensive care setting. No data is available on HFNC use in the general …